Abnormal brain development in child and adolescent carriers of mutant huntingtin
Ellen van der Plas(Arkansas Children's Hospital), Peg Nopoulos(University of Iowa), Amy L. Conrad(University of Iowa Hospitals and Clinics), Timothy R. Koscik(University of Iowa Hospitals and Clinics), Eric A. Epping(University of Iowa Hospitals and Clinics), Douglas R. Langbehn(University of Iowa Hospitals and Clinics), Vincent A. Magnotta(University of Iowa), А.В. Терещенко(University of Iowa Hospitals and Clinics)
Cited by 96
Related Papers
Executive control deficits in substance-dependent individuals: A comparison of alcohol, cocaine, and methamphetamine and of men and women
|Journal of Clinical and Experimental Neuropsychology|2008|200
Non-linear MHD simulations of edge localized modes (ELMs)
|Plasma Physics and Controlled Fusion|2009|147
Huntingtin suppression restores cognitive function in a mouse model of Huntington’s disease
|Science Translational Medicine|2018|123
Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study
|The Lancet Neurology|2018|108
Amygdala volume correlates positively with fearfulness in normal healthy girls
|Social Cognitive and Affective Neuroscience|2010|99